BioCentury | Feb 18, 2015
Company News

Management tracks

...Armetheon Inc. (Menlo Park, Calif.) hired John Glenn as CFO. Glenn was previously CFO of Solta Medical Inc....
BioCentury | Jan 27, 2014
Company News

Solta, Valeant Pharmaceuticals deal

...Solta for $2.92 per share in cash, or about $250 million (see BioCentury, Jan. 6). Solta Medical Inc....
BioCentury | Jan 6, 2014
Company News

Solta, Valeant Pharmaceuticals deal

...Valeant will acquire aesthetic device company Solta for $2.92 per share in cash, or about $250...
...per share in cash, or about $250 million. The price is a 40% premium to Solta's...
...on Dec. 13, 2013, before the deal was disclosed. The deal has been approved by Solta's...
BioCentury | Apr 30, 2012
Finance

Foreseeing liquidity

...Inc. ; Puma Biotechnology Inc . (OTCBB:PBYI); Tarsa Therapeutics Inc. ; and dermatology device company Solta Medical Inc....
BioCentury | Nov 7, 2011
Company News

Medicis, Solta deal

...is approved in the U.S. (see BioCentury, Sept. 19). Medicis Pharmaceutical Corp. (NYSE:MRX), Scottsdale, Ariz. Solta Medical Inc....
BioCentury | Sep 19, 2011
Company News

Medicis, Solta deal

...based on regulatory milestones and year-to-year performance increases of the subsidiary's Liposonix fat ablation system. Solta...
...is approved in the U.S. Details were not disclosed. Medicis Pharmaceutical Corp. (NYSE:MRX), Scottsdale, Ariz. Solta Medical Inc....
BioCentury | Mar 28, 2011
Company News

Myoscience management update

...Redwood City, Calif. Business: Dermatology Hired: Clint Carnell as president and CEO, formerly COO of Solta Medical Inc. WIR...
Items per page:
1 - 7 of 7
BioCentury | Feb 18, 2015
Company News

Management tracks

...Armetheon Inc. (Menlo Park, Calif.) hired John Glenn as CFO. Glenn was previously CFO of Solta Medical Inc....
BioCentury | Jan 27, 2014
Company News

Solta, Valeant Pharmaceuticals deal

...Solta for $2.92 per share in cash, or about $250 million (see BioCentury, Jan. 6). Solta Medical Inc....
BioCentury | Jan 6, 2014
Company News

Solta, Valeant Pharmaceuticals deal

...Valeant will acquire aesthetic device company Solta for $2.92 per share in cash, or about $250...
...per share in cash, or about $250 million. The price is a 40% premium to Solta's...
...on Dec. 13, 2013, before the deal was disclosed. The deal has been approved by Solta's...
BioCentury | Apr 30, 2012
Finance

Foreseeing liquidity

...Inc. ; Puma Biotechnology Inc . (OTCBB:PBYI); Tarsa Therapeutics Inc. ; and dermatology device company Solta Medical Inc....
BioCentury | Nov 7, 2011
Company News

Medicis, Solta deal

...is approved in the U.S. (see BioCentury, Sept. 19). Medicis Pharmaceutical Corp. (NYSE:MRX), Scottsdale, Ariz. Solta Medical Inc....
BioCentury | Sep 19, 2011
Company News

Medicis, Solta deal

...based on regulatory milestones and year-to-year performance increases of the subsidiary's Liposonix fat ablation system. Solta...
...is approved in the U.S. Details were not disclosed. Medicis Pharmaceutical Corp. (NYSE:MRX), Scottsdale, Ariz. Solta Medical Inc....
BioCentury | Mar 28, 2011
Company News

Myoscience management update

...Redwood City, Calif. Business: Dermatology Hired: Clint Carnell as president and CEO, formerly COO of Solta Medical Inc. WIR...
Items per page:
1 - 7 of 7